DK1194559T3 - Grupper af Borrelia burgdorferi, som forårsager Lyme sygdom hos mennesker - Google Patents

Grupper af Borrelia burgdorferi, som forårsager Lyme sygdom hos mennesker

Info

Publication number
DK1194559T3
DK1194559T3 DK00942966T DK00942966T DK1194559T3 DK 1194559 T3 DK1194559 T3 DK 1194559T3 DK 00942966 T DK00942966 T DK 00942966T DK 00942966 T DK00942966 T DK 00942966T DK 1194559 T3 DK1194559 T3 DK 1194559T3
Authority
DK
Denmark
Prior art keywords
lyme disease
humans
groups
ospc
borrelia burgdorferi
Prior art date
Application number
DK00942966T
Other languages
Danish (da)
English (en)
Inventor
Raymond J Dattwyler
Gerald Seinost
Daniel Dykhuizen
Benjamin J Luft
Maria Gomes-Solecki
Original Assignee
Univ New York State Res Found
Brook Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found, Brook Biotechnologies Inc filed Critical Univ New York State Res Found
Application granted granted Critical
Publication of DK1194559T3 publication Critical patent/DK1194559T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK00942966T 1999-06-18 2000-06-19 Grupper af Borrelia burgdorferi, som forårsager Lyme sygdom hos mennesker DK1194559T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14004299P 1999-06-18 1999-06-18
PCT/US2000/016915 WO2000078966A1 (fr) 1999-06-18 2000-06-19 Groupes de borrelia burgdorferi et de borrelia afzelii provoquant la maladie de lyme chez l'homme

Publications (1)

Publication Number Publication Date
DK1194559T3 true DK1194559T3 (da) 2007-02-05

Family

ID=22489483

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00942966T DK1194559T3 (da) 1999-06-18 2000-06-19 Grupper af Borrelia burgdorferi, som forårsager Lyme sygdom hos mennesker

Country Status (9)

Country Link
US (2) US7060281B1 (fr)
EP (2) EP1683867B1 (fr)
AT (1) ATE340262T1 (fr)
AU (1) AU5751000A (fr)
DE (1) DE60030859T2 (fr)
DK (1) DK1194559T3 (fr)
ES (1) ES2272296T3 (fr)
PT (1) PT1194559E (fr)
WO (1) WO2000078966A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2272296T3 (es) * 1999-06-18 2007-05-01 Research Foundation Of State University Of New York Grupos de borrelia burgdorferi que producen la enfermedad de lyme en humanos.
EP1939294A1 (fr) 2000-08-18 2008-07-02 Research Foundation Of State University Of New York Structures recombinantes de borrelia burgdorferi
GB2414667A (en) * 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
US8821893B2 (en) * 2004-07-02 2014-09-02 Bio Peptides, Corp. Oral vaccine for Borrelia
US7794727B2 (en) 2005-11-29 2010-09-14 Virginia Commonwealth University Polyvalent chimeric OspC vaccinogen and diagnostic antigen
EA013219B1 (ru) 2006-01-19 2010-04-30 Мэри Кэй, Инк. Композиция местного применения по уходу за кожей, продукт на ее основе и способ лечения
EP2361930A3 (fr) 2007-03-26 2011-10-26 Dako Denmark A/S Multimeres du complexes peptide-cmh et leur utilisation dans des maladies infectieuses de borrelia
EP3023436A1 (fr) 2007-07-03 2016-05-25 Dako Denmark A/S Procédés améliorés pour produire, marquer et utiliser des multimères du cmh
WO2009039854A2 (fr) 2007-09-27 2009-04-02 Dako Denmark A/S Multimères cmh dans le diagnostic, le vaccin et le traitement de la tuberculose
DK2254592T3 (da) 2008-02-28 2019-09-09 Dako Denmark As MHC-multimerer til Borrelia-diagnostik og sygdom
WO2009131665A1 (fr) 2008-04-22 2009-10-29 Research Foundation Of State University Of New York Réseau de protéines d'enveloppes de cellules de borrelia burgdorferi
US10722562B2 (en) 2008-07-23 2020-07-28 Immudex Aps Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
WO2010037402A1 (fr) 2008-10-02 2010-04-08 Dako Denmark A/S Vaccins moléculaires contre les maladies infectieuses
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
WO2010132758A2 (fr) * 2009-05-14 2010-11-18 Gomes-Solecki Maria J Test de diagnostic à base de ospc pour la maladie de lyme
FR2949472B1 (fr) 2009-08-28 2013-08-09 Biomerieux Sa Proteines utilisees pour le diagnostic d'une borreliose de lyme
CA2772626C (fr) 2009-08-28 2013-12-10 Mary Kay Inc. Compositions de soin de la peau
EP3029073B1 (fr) * 2010-10-20 2019-09-04 Virginia Commonwealth University Antigène ospc chimère polyvalent vaccinogène et diagnostique
US20160097768A1 (en) 2010-10-20 2016-04-07 Virginia Commonwealth University Polyvalent chimeric ospc vaccinogen and diagnostic antigen
US10100092B2 (en) 2011-11-03 2018-10-16 Vca, Inc. Compositions and methods to detect various infectious organisms
WO2013116668A2 (fr) * 2012-02-01 2013-08-08 Biopeptides Corp Peptides diagnostiques pour la maladie de lyme
US9562079B2 (en) 2012-04-18 2017-02-07 Zoetis Services Llc Vaccines and methods to treat lyme disease in dogs
RU2514230C1 (ru) * 2012-12-14 2014-04-27 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт биохимии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИ биохимии" СО РАМН) Рекомбинантные химерные полипептиды, несущие эпитопы различных иммунодоминантных белков спирохет комплекса borrelia burgdorferi sensu lato, и способ серодиагностики иксодового клещевого боррелиоза
EP3213076A1 (fr) 2014-10-07 2017-09-06 The Research Foundation for The State University of New York Protéines recombinantes de borrelia et utilisation de celles-ci
EP3359558B1 (fr) 2015-10-06 2023-12-13 Bio-Rad Laboratories, Inc. Dosages immunologiques de borrelia et matériaux associés

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646016A (en) * 1991-02-06 1997-07-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
US6221363B1 (en) 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
CA2157004A1 (fr) 1993-02-26 1994-09-01 Richard T. Coughlin Methodes d'immunisation contre la maladie de lyme et dosage colorimetrique de l'activite borreliacide des antiserums
DE69408135T2 (de) 1993-04-29 1998-06-10 Immuno Ag Ospc-antigen-impfstoffe immunogene zusammensetzung zur vorbeugung und behandlung von lyme-krankheit und rekombinante verfahren zur herstellung von derartige antigene
DE69433690T2 (de) * 1993-11-01 2005-03-10 Brookhaven Science Associates Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
WO1995026985A1 (fr) * 1994-04-05 1995-10-12 Board Of Regents, The University Of Texas System Recepteurs modifies a signalisation continue
AR003941A1 (es) * 1995-04-19 1998-09-30 Polymun Scient Immunbilogische Forschung Gmbh Anticuerpos monoclonales humanos neutralizadores de hiv-1
US5804427A (en) * 1995-05-19 1998-09-08 University Of Massachusetts Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
US5683903A (en) * 1995-05-30 1997-11-04 Smithkline Beecham Corporation Attachment enhanced 293 cells
US6251405B1 (en) 1995-06-07 2001-06-26 Connaught Laboratories, Inc. Immunological combination compositions and methods
US5849891A (en) * 1995-07-28 1998-12-15 National Science Council Satellite RNA from bamboo mosaic virus as a vector for foreign gene expression in plants
GB9517585D0 (en) * 1995-08-29 1995-11-01 Cookson William O C Atopy diagnosis and therapy
US5756294A (en) * 1995-09-25 1998-05-26 Oncormed, Inc. Susceptibility mutation for breast and ovarian cancer
GB9526218D0 (en) * 1995-12-21 1996-02-21 Gene Shears Pty Ltd DNA Sequences
US6255464B1 (en) * 1996-04-18 2001-07-03 The Johns Hopkins University Mad-related genes in the human
CA2253374C (fr) 1996-05-02 2004-07-20 Marianne Jartved Mathiesen Nouveaux fragments peptidiques derives de ospc
US6110703A (en) * 1996-07-05 2000-08-29 Novo Nordisk A/S Method for the production of polypeptides
US5824318A (en) * 1996-07-24 1998-10-20 American Cyanamid Company Avirulent herpetic viruses useful as tumoricidal agents and vaccines
WO1998011216A1 (fr) * 1996-09-11 1998-03-19 Sumitomo Pharmaceuticals Company, Limited Nouveau gene de semaphorine: semaphorine y
US6131578A (en) * 1996-10-02 2000-10-17 King; George L. Inhibitors of UDP-G1cNAc:Ga1β1-3Ga1NAcαR β1-6 N-acetylglucosaminyltransferase (core 2 G1cNAc-T) and use of the inhibitors to prevent or treat cardiomyopathy associated with diabetes
AU6546898A (en) 1997-03-11 1998-09-29 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
US6420108B2 (en) * 1998-02-09 2002-07-16 Affymetrix, Inc. Computer-aided display for comparative gene expression
DE19740735A1 (de) 1997-09-16 1999-03-18 Max Planck Gesellschaft Arzneimittel zur Therapie einer manifesten Lyme-Borreliose
US6194556B1 (en) * 1997-12-11 2001-02-27 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therfor
US6150081A (en) * 1997-12-24 2000-11-21 Fuji Photo Film B.V. Silver halide emulsions with recombinant collagen suitable for photographic application and also the preparation thereof
WO1999041379A2 (fr) * 1998-02-17 1999-08-19 Institut National De La Sante Et De La Recherche Medicale Membres de la famille de genes d52
KR100630277B1 (ko) * 1998-04-01 2006-09-29 대니스코 에이/에스 전분의 노화를 지연시키는 넌-말토제닉 엑소아밀라제와그들의 사용
US6245525B1 (en) * 1998-07-27 2001-06-12 Ludwig Institute For Cancer Research Tumor associated nucleic acids and uses therefor
WO1999055840A1 (fr) * 1998-04-27 1999-11-04 The Regents Of The University Of California Facteur de transcription et technique permettant de reguler la croissance, la qualite et la tolerance au stress des semences
ES2302385T3 (es) 1998-07-31 2008-07-01 Gundersen Lutheran Medical Foundation, Inc. Uso de epitopo(s) borrelicida(s) de la proteina c de superficie externa de borrelia burgdorferi como vacuna.
US6627193B1 (en) * 1999-01-13 2003-09-30 University Of Georgia Research Foundation, Inc. Methods and compositions for control of blood coagulation
US6468773B1 (en) * 1999-05-19 2002-10-22 Genencor International, Inc. Mutant 1,3-propandiol dehydrogenase
ES2272296T3 (es) 1999-06-18 2007-05-01 Research Foundation Of State University Of New York Grupos de borrelia burgdorferi que producen la enfermedad de lyme en humanos.
WO2001013105A1 (fr) * 1999-07-30 2001-02-22 Agy Therapeutics, Inc. Techniques facilitant l'identification de genes candidats
US6472154B1 (en) * 1999-12-31 2002-10-29 Board Of Regents, The University Of Texas System Polymorphic repeats in human genes
US6337208B1 (en) * 2000-01-03 2002-01-08 Stefan Graupner Cloning vector

Also Published As

Publication number Publication date
DE60030859D1 (de) 2006-11-02
US7582304B2 (en) 2009-09-01
US7060281B1 (en) 2006-06-13
EP1683867A1 (fr) 2006-07-26
WO2000078966A1 (fr) 2000-12-28
EP1194559A1 (fr) 2002-04-10
US20090060932A2 (en) 2009-03-05
EP1683867B1 (fr) 2014-04-09
PT1194559E (pt) 2007-01-31
ES2272296T3 (es) 2007-05-01
EP1194559B1 (fr) 2006-09-20
DE60030859T2 (de) 2007-06-14
AU5751000A (en) 2001-01-09
US20060182756A1 (en) 2006-08-17
ATE340262T1 (de) 2006-10-15

Similar Documents

Publication Publication Date Title
DK1194559T3 (da) Grupper af Borrelia burgdorferi, som forårsager Lyme sygdom hos mennesker
DE60226687D1 (de) Steuerungssystem für Schaltungsgruppen
EP2279753A3 (fr) Remodelage et gluco-conjugaison de peptides
DE59911989D1 (de) Knochendistraktionsvorrichtung
DE60224776D1 (de) Virtuelles Bildtelefon
DE69907137D1 (de) Autoklavierbare pharmazeutische zusammensetzungen mit komplexbildner
RS50101B (sr) Farmaceutski preparati za imunomodulaciju
ATE345133T1 (de) Laktose-freie, nicht-hygroskopische und wasserfreie pharmazeutische zusammensetzungen von descarboethoxyloratadin
DE69739069D1 (de) Treiberschaltung fur last
ATE381575T1 (de) Veränderte borrelia burgdorferi ospa
DE50203420D1 (de) Aktorsystem
DK1311682T3 (da) Rekombinante konstruktioner af Borrelia burgdorferi
DK1147212T3 (da) T-hjælpecelle-epitoper
ATE323095T1 (de) 3,7-diazabicycloc3.3.1)-formulierungen als antiarrhythmika
NO20073914L (no) Biologisk aktive peptider
DE69933647D1 (de) Rekombinante lysophosphatidsäure - phosphatase.
DK1219301T3 (da) Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner
PT1159960E (pt) Composicoes farmaceuticas baseadas em diclofenac
PT1232183E (pt) Peptidos possuindo actividade anti-angiogenica
ATE369137T1 (de) Lyophilisierte formulierung enthaltend olanzapin
ID26951A (id) Vaksin mycoplasma hyopneumontae recombinan
EP2305312A3 (fr) Remodelage et glycoconjugation de l'hormone folliculo-stimulante (FSH)
SE9904404L (sv) Ny komposition
ITTO20010049A0 (it) Unita' di connessione.
DE60231432D1 (de) Steuersystem